Thrombosis Cardiac
5
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
9 treatments under study, led by 50 Ml Syringe Manual Thrombectomy Catheter
Research Leaders
14 sponsors active, led by China National Center for Cardiovascular Diseases
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Intraventricular Stasis In Cardiovascular Disease
Cerebral Microembolization Associated With PFO Closure
18F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis
Efficacy of Using 50 ml Syringe Manual Thrombectomy Catheter in Primary PCI With Heavy Thrombus Burden
The Thrombotic Potential of Heart Chambers in the Presence or Absence of Atrial Fibrillation.
Research Network
Common Treatments
- 50 Ml Syringe Manual Thrombectomy Catheter1
- 18fgp11
- Cardiac Magnetic Resonance1
- 30 Ml Syringe Manual Thrombectomy Catheter1
- Brain Magnetic Resonance1
Active Sponsors
- China National Center for Cardiovascular Diseases1
- Beijing Tiantan Hospital1
- Helwan University1
- University of Edinburgh1
- Beijing Anzhen Hospital1
Top Investigators
Helwan University
University of Edinburgh
Hospital General Universitario Gregorio Marañon
Cardiovascular Institute and Fuwai Hospital
Related Conditions
- Aortic Valve Disease1
- Stroke1
- Hypertrophic Cardiomyopathy1
- Atrial Septal Defect1
- Atrial Fibrillation1